To help guide the selection of treatment in patients with severe asthma, currently available biomarkers such as peripheral blood and induced sputum eosinophil count, fraction of exhaled nitric oxide (FeNO) level, and immunoglobulin-E (IgE) levels have been used [10]. Here, IGHE is linked to asthma.